Study Shows Merits of Photon-Counting CT in Detecting Subtle Post-COVID Lung Abnormalities
In a recently published prospective study comparing photon-counting detector computed tomography (PCD CT) versus energy-integrating detector CT (EID CT) in patients with persistent symptoms after COVID-19 infection, researchers found that PCD CT discovered additional lung abnormalities in half of the study participants.
Recognizing and Addressing Biases with AI and Radiologists
In a video interview discussing one of her recent lectures at the Radiological Society for North America (RSNA) conference, Nina Kottler, M.D., M.S., noted how the combination of artificial intelligence (AI) and radiologist experience can help mitigate bias limitations with the development of AI algorithms as well as educational biases inherent to a radiologist’s training and experience.
Cytalux Gets Expanded FDA Approval for Intraoperative Imaging of Lung Cancer
Reportedly the first targeted molecular imaging agent to provide intraoperative illumination of lung cancer, Cytalux (pafolacianine) helped identify clinically significant events in more than 50 percent of patients undergoing surgery for confirmed or suspected pulmonary nodules, according to Phase 3 trial data presented earlier this year at the American Association for Thoracic Surgery Annual Meeting.